Thalidomide Improves Prognosis in Refractory Neurosarcoidosis: A Case Report
Author Information
Author(s): Hoyle J Chad, Newton Herbert B, Katz Steven
Primary Institution: The Ohio State University Medical Center and James Cancer Hospital & Solove Research Institute
Hypothesis
Can thalidomide alter the prognosis of patients with refractory neurosarcoidosis?
Conclusion
The addition of thalidomide led to significant clinical improvement in a patient with refractory neurosarcoidosis.
Supporting Evidence
- The patient had previously failed multiple treatments including high-dose steroids and other immunosuppressants.
- After starting thalidomide, the patient showed radiologic improvement within two months.
- Clinical symptoms stabilized and improved over the following months.
Takeaway
A woman with a tough brain condition got better after taking a medicine called thalidomide, which helped her when other treatments didn't work.
Methodology
The patient was treated with thalidomide after failing multiple conventional treatments, with follow-up MRI scans to assess improvement.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
40-year-old African-American female.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website